News & Updates
Filter by Specialty:
Study supports safety of fourth BNT162b2 mRNA vaccine
A study from Israel validated the safety of the fourth BNT162b2 mRNA COVID-19 vaccine (ie, second booster) using data from a retrospective and a prospective cohort.
Study supports safety of fourth BNT162b2 mRNA vaccine
01 Feb 2023
BNT162b2 vax prevents delta, omicron infection in adolescents; benefits upped with booster dose
Full vaccination with the SARS-CoV-2 BNT162b2 vaccine reduced infection and hospitalization due to the delta and omicron variants of the SARS-CoV-2 infection, with an added benefit against the omicron variant in individuals who received a booster dose, according to a national study of Singaporean adolescents.
BNT162b2 vax prevents delta, omicron infection in adolescents; benefits upped with booster dose
30 Jan 2023
Long COVID may persist for months, resolve within a year
Patients with mild COVID-19 may encounter a few health concerns for several months following SARS-CoV-2 infection, but these outcomes tend to resolve within a year from diagnosis, reveals a study.
Long COVID may persist for months, resolve within a year
30 Jan 2023
SAVE-MORE subgroup analysis further reinforces anakinra benefit in COVID-19
The benefit of anakinra treatment in patients hospitalized with COVID-19 is consistent regardless of age, sex, comorbidities, and suPAR* levels, according to subgroup analysis of the SAVE-MORE trial.
SAVE-MORE subgroup analysis further reinforces anakinra benefit in COVID-19
27 Jan 2023
POSEIDON: Dual ICIs plus chemo up survival in first-line mNSCLC
POSEIDON: Dual ICIs plus chemo up survival in first-line mNSCLC
20 Jan 2023
Total diet replacement shows promise for difficult-to-treat asthma
A low-calorie total diet replacement program (Counterweight-Plus) is safe and improves asthma control and quality of life in patients with difficult-to-treat asthma and obesity, according to 16-week data from a recent study.
